03-Sep-2020 | Facts and Factors
Findings from Facts and Factors report “Therapeutic Drug Monitoring Market by Product (Consumables and Equipment), By Technology (Immunoassays, Colorimetric Immunoassays, Radioimmunoassays, Other immunoassays, and Chromatography-MS), by Class of Drug (Antiepileptic drugs, Antiarrhythmic drugs, Immunosuppressant Drugs, Antibiotic drugs, Bronchodilator drugs, Psychoactive drugs, and Other drug classes), by End-user (Hospital laboratories, Commercial/private laboratories, and Other end-users) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global therapeutic drug monitoring market in 2019 was approximately USD 1296.0 Million. The market is expected to grow at a CAGR of 5.8% and is anticipated to reach around USD 1923.18 Million by 2026.
Therapeutic Drug Management measures the concentration of a drug in the blood at scheduled intervals. The Therapeutic Drug Management (TDM) is used to assess the dosage at which the medication is most safe and reliable. The COVID-19, an emerging, rapidly evolving situation has become a factor that is creating a huge demand for the therapeutic drug monitoring and intern boosting the growth of the global market. Increased use of TDM in traditional anticancer therapies, coupled with an increasing number of organ transplantation procedures around the globe, are factors driving the growth of the global market. Nevertheless, the inability of small hospitals to provide TDM services is a concern that is projected to impede the development of the global industry in the immediate future. Monitoring of biosimilars in autoimmune diseases can create growth opportunities in the global market in the future.
Browse the full “Therapeutic Drug Monitoring Market by Product (Consumables and Equipment), By Technology (Immunoassays, Colorimetric Immunoassays, Radioimmunoassays, Other immunoassays, and Chromatography-MS), by Class of Drug (Antiepileptic drugs, Antiarrhythmic drugs, Immunosuppressant Drugs, Antibiotic drugs, Bronchodilator drugs, Psychoactive drugs, and Other drug classes), by End-user (Hospital laboratories, Commercial/private laboratories, and Other end-users) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/therapeutic-drug-monitoring-market-by-product-consumables-and-1274
Report Scope
Report Attributes |
Details |
Market Size in 2019 |
USD 1296.0 Million |
Projected Market Size in 2026 |
USD 1923.18 Million |
Growth Rate |
CAGR 5.8% |
Base Year |
2019 |
Forecast Years |
2020–2026 |
Key Market Players |
Abbott Laboratories, Danaher Corporation, Biomérieux, Bühlmann Laboratories, Randox Laboratories Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, and Sekisui Medical. Key operating players in the global therapeutic drug monitoring market are aiming towards mergers and acquisitions in order to get a competitive edge in the market. |
Key Segment |
By Product, By Technology, By Class of Drug, By End User, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
The global therapeutic drug monitoring market is segmented on the basis of product, class of drug, technology, and end-user. On the basis of product type, the global market is categorized into consumables and equipment. Based on technology the global market is bifurcated into immunoassays, colorimetric immunoassays, radioimmunoassays, other immunoassays, and chromatography-MS. The global market is segmented into antiepileptic drugs, antiarrhythmic drugs, immunosuppressant drugs, antibiotic drugs, bronchodilator drugs, psychoactive drugs, and other drug classes, depending upon the class of the drugs. Also, the end-users in the global market includes hospital laboratories, commercial/private laboratories, and other end-users
Based upon the region the global market has been categorized as North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America is expected to dominate in the global market in terms of revenue as compared to that of markets in other regions during the forecast period 2020-2026. This is attributed to increasing per capita expenditure on healthcare and the presence of technologically advanced healthcare infrastructure in the region. Initiatives taken by different government associations are also expected to boost the market growth in the coming years. The growth in the Asia Pacific countries is the presence of a favorable business environment in the countries of the Asia Pacific. Asian countries, particularly China, India, and Japan, are showing the highest rates of health spending growth. This, together with the rapidly growing geriatric population and increasing disposable income, makes the Asia Pacific an attractive market for the target market.
Key players operating in the therapeutic drug monitoring market not restricted to include Abbott Laboratories, Danaher Corporation, Biomérieux, Bühlmann Laboratories, Randox Laboratories Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, and Sekisui Medical. Key operating players in the global therapeutic drug monitoring market are aiming towards mergers and acquisitions in order to get a competitive edge in the market.
This report segments the therapeutic drug monitoring market as follows:
Global Therapeutic Drug Monitoring Market: By Product
- Consumables
- Equipment
- Immunoassay analyzers
- Chromatography and MS detectors
- Clinical chemistry analyzers
Global Therapeutic Drug Monitoring Market: By Technology
- Immunoassays
- Chemiluminescent immunoassays
- Fluorescence immunoassays
- Colorimetric Immunoassays
- Radioimmunoassays
- Other immunoassays
- Chromatography-MS
- Liquid Chromatography/Mass Spectrometry
- Gas Chromatography-Mass Spectrometry
Global Therapeutic Drug Monitoring Market: By Class of Drug
- Antiepileptic drugs
- Antiarrhythmic drugs
- Immunosuppressant drugs
- Antibiotic drugs
- Bronchodilator drugs
- Psychoactive drugs
- Other drug classes
Global Therapeutic Drug Monitoring Market: By End User
- Hospital laboratories
- Commercial/private laboratories
- Other end users
Global Therapeutic Drug Monitoring Market: Regional Segmentation Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
